MENU
NEWSLETTERS
MENU
SECTIONS
OTHER
CLASSIFIEDS
CONTACT US / FAQ
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Turning Point Therapeutics, Inc. - Common stock (NQ:TPTX)

N/A UNCHANGED
Last Price Updated: 4:00 PM EDT, Aug 16, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open -
Bid (Size) 75.98 (9)
Ask (Size) 76.00 (7)
Prev. Close 76.01
Today's Range N/A - N/A
52wk Range N/A - N/A
Shares Outstanding 50,074,277
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Bristol Myers Squibb and Turning Point Therapeutics Announce Expiration of HSR Act Waiting Period and Clearance from Federal Cartel Office of Germany Related to Pending Acquisition of Turning Point Therapeutics
From Bristol Myers Squibb
Via Business Wire
News headline image
Blue Chip Stocks In Focus: Bristol-Myers Squibb ↗
The company has grown earnings by more than 20% per year on average over the last five and ten years. This explosive growth has enabled the company to continue growing its dividend. 
Via Talk Markets

Performance

More News

Read More
News headline image
Recap of Wednesday's Biotech Catalysts - End of The Day Summary ↗
Via Benzinga
News headline image
Analyst Ratings for Turning Point ↗
Via Benzinga
News headline image
Turning Point Secures Positive FDA Feedback For Planned Lung Cancer Drug Submission ↗
Via Benzinga
News headline image
The 3 Best Market Sectors for the Second Half of 2022 ↗
Via InvestorPlace
News headline image
TPTX Stock Alert: Halper Sadeh LLP Is Investigating Whether the Sale of Turning Point Therapeutics, Inc. Is Fair to Shareholders
From Halper Sadeh LLP
Via Business Wire
News headline image
TURNING POINT THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Turning Point Therapeutics, Inc. - TPTX
From Kahn Swick & Foti, LLC
Via Business Wire
News headline image
UnitedHealth, Shockwave Lead 5 Healthy Stocks Breaking Out Or Setting Up ↗
Via Investor's Business Daily
News headline image
INVESTIGATION ALERT: Halper Sadeh LLP Investigates VMW, TPTX, CTT, CTEK
From Halper Sadeh LLP
Via AccessWire
News headline image
10 Biggest Price Target Changes For Monday ↗
Via Benzinga
News headline image
TURNING POINT THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Turning Point Therapeutics, Inc. - TPTX
From Kahn Swick & Foti, LLC
Via Business Wire
News headline image
69 Biggest Movers From Friday ↗
Via Benzinga
News headline image
The Week Ahead In Biotech (June 5-11): Adcom Test For Novavax, ASCO Presentations, Enzo Biochem Earnings And More ↗
Via Benzinga
News headline image
The Acquisition of Turning Point Therapeutics By BMY- Bristol- Myers.
Via Best Stocks
News headline image
Mid-Afternoon Market Update: Gold Drops 1%; Sprague Resources Shares Spike Higher ↗
Via Benzinga
News headline image
12 Health Care Stocks Moving In Friday's Intraday Session ↗
Via Benzinga
News headline image
Mid-Day Market Update: Nasdaq Down 300 Points; Turning Point Therapeutics Shares Jump ↗
Via Benzinga
News headline image
40 Stocks Moving In Friday's Mid-Day Session ↗
Via Benzinga
News headline image
TPTX Stock Alert: Halper Sadeh LLP Is Investigating Whether the Sale of Turning Point Therapeutics, Inc. Is Fair to Shareholders
From Halper Sadeh LLP
Via Business Wire
News headline image
CrowdStrike (CRWD) Stock Dips Despite Earnings Beat ↗
Via InvestorPlace
News headline image
TPTX Stock Soars 115% as Bristol Myers Announces Takeover of Turning Point Therapeutics ↗
Via InvestorPlace
News headline image
Mid-Morning Market Update: Markets Open Lower; US Economy Adds 390,000 Jobs In May ↗
Via Benzinga
News headline image
Bristol Myers Snaps Up Turning Point For $4.1 Billion In Cash — Is The Biotech Bear Dead? ↗
Via Investor's Business Daily
News headline image
12 Health Care Stocks Moving In Friday's Pre-Market Session ↗
Via Benzinga

Frequently Asked Questions

Is Turning Point Therapeutics, Inc. - Common stock publicly traded?
Yes, Turning Point Therapeutics, Inc. - Common stock is publicly traded.
What exchange does Turning Point Therapeutics, Inc. - Common stock trade on?
Turning Point Therapeutics, Inc. - Common stock trades on the Nasdaq Stock Market
What is the ticker symbol for Turning Point Therapeutics, Inc. - Common stock?
The ticker symbol for Turning Point Therapeutics, Inc. - Common stock is TPTX on the Nasdaq Stock Market
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story